Abstract:A multilevel approach was implemented in Saccharomyces cerevisiae to optimize the precursor module of the aromatic amino acid biosynthesis pathway, which is a rich resource for synthesizing a great variety of chemicals ranging from polymer precursor, to nutraceuticals and pain-relief drugs. To facilitate the discovery of novel targets to enhance the pathway flux, we incorporated the computational tool YEASTRACT for predicting novel transcriptional repressors and OptForce strain-design for identifying non-intuitive pathway interventions. The multilevel approach consisted of (i) relieving the pathway from strong transcriptional repression, (ii) removing competing pathways to ensure high carbon capture, and (iii) rewiring precursor pathways to increase the carbon funneling to the desired target. The combination of these interventions led to the establishment of a S. cerevisiae strain with shikimic acid (SA) titer reaching as high as 2.5gL<sup>-1</sup>, 7-fold higher than the base strain. Further expansion of the platform led to the titer of 2.7gL<sup>-1</sup> of muconic acid (MA) and its intermediate protocatechuic acid (PCA) together. Both the SA and MA production platforms demonstrated increases in titer and yield nearly 300% from the previously reported, highest-producing S. cerevisiae strains. Further examination elucidated the diverged impacts of disrupting the oxidative branch (ZWF1) of the pentose phosphate pathway on the titers of desired products belonging to different portions of the pathway. The investigation of other non-intuitive interventions like the deletion of the Pho13 enzyme also revealed the important role of the transaldolase in determining the fate of the carbon flux in the pathways of study. This integrative approach identified novel determinants at both transcriptional and metabolic levels that constrain the flux entering the aromatic amino acid pathway. In the future, this platform can be readily used for engineering the downstream modules toward the production of important plant-sourced aromatic secondary metabolites.

A self-regulated network for dynamically balancing multiple precursors in complex biosynthetic pathways

Construction Of A Controllable Beta-Carotene Biosynthetic Pathway By Decentralized Assembly Strategy In Saccharomyces Cerevisiae

Switching Carbon Metabolic Flux for Enhancing the Production of Sesquiterpene-Based High-Density Biofuel Precursor in Saccharomyces Cerevisiae

Combinatorial Optimization of MEP Pathway to Improve β-Carotene Yield

Designing pathways for bioproducing complex chemicals by combining tools for pathway extraction and ranking

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Sequential control of biosynthetic pathways for balanced utilization of metabolic intermediates in Saccharomyces cerevisiae.

Co‐Cultivated Enzyme Constraint Metabolic Network Model for Rational Guidance in Constructing Synthetic Consortia to Achieve Optimal Pathway Allocation Prediction

CF-Targeter: A Rational Biological Cell Factory Targeting Platform for Biosynthetic Target Chemicals

OP-Synthetic: Identification of Optimal Genetic Manipulations for the Overproduction of Native and Non-Native Metabolites

Assembly of Biosynthetic Pathways in Saccharomyces Cerevisiae Using a Marker Recyclable Integrative Plasmid Toolbox

Probing Biomass Precursor Synthesis as a Key Factor in Microbial Adaptation to Unadapted Carbon Sources

Multilevel engineering of the upstream module of aromatic amino acid biosynthesis in Saccharomyces cerevisiae for high production of polymer and drug precursors

Design of stable and self-regulated microbial consortia for chemical synthesis

Pathway Evolution Through a Bottlenecking-Debottlenecking Strategy and Machine Learning-Aided Flux Balancing

Development of a growth coupled and multi-layered dynamic regulation network balancing malonyl-CoA node to enhance (2S)-naringenin biosynthesis in Escherichia coli

Biosynth Pipeline: An integrated platform for merging the computational design of chimeric type I polyketide synthases with enzymatic pathways for chemical biosynthesis

In Vitro Reconstitution Guide for Targeted Synthetic Metabolism of Chemicals, Nutraceuticals and Drug Precursors

Modulation of nutrient precursors for controlling metabolic inhibitors by genome-scale flux balance analysis

Designing artificial pathways for improving chemical production

Modular enzyme assembly for enhanced cascade biocatalysis and metabolic flux